Gossamer Bio, Inc. (GOSS)
Develops inhaled drugs to treat lung hypertension diseases
$0.20-0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-90.2%
The outlook
GOSS is trading near its 52-week low, with an overall analyst lean that's bearish. The stock sits well below its moving averages, though analysts' average price target sits significantly above the current price. Coverage and near-term momentum remain weak.
What’s behind the score
Price trendMixed vs its moving averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +1871% vs current price
Analyst price target
~12-month · 5 analysts$3.86average target+1871.4% vs now
Now $0.20
Low $0.28High $15.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$95.6M
52-wk high
$3.87
52-wk low
$0.11
50-day avg
$0.18
200-day avg
$1.43
Trailing P/E
—